Title : Hepatitis C - Vosevi safe, effective in ‘triple-infected’ patients with HCV, HBV, HIV
link : Hepatitis C - Vosevi safe, effective in ‘triple-infected’ patients with HCV, HBV, HIV
Hepatitis C - Vosevi safe, effective in ‘triple-infected’ patients with HCV, HBV, HIV
Vosevi safe, effective in ‘triple-infected’ patients with HCV, HBV, HIVPHILADELPHIA – The direct-acting antiviral Vosevi demonstrated an average sustained virologic response rate of 87% among patients who were “triple-infected” with hepatitis C genotype 3, hepatitis B and HIV, as presented at the American College of Gastroenterology Annual Meeting.
“Chronic hepatitis C treatment is no longer challenging in the era of DAAs with an SVR of up to 97%. However, triple infection treatment with HCV, HIV and hepatitis B has not been explored in real life situations,” Nimy John, MD, from the University of Massachusetts Medical School, said during her presentation.
Healio Coverage:
See more from American College of Gastroenterology Annual Meeting
Thus Article Hepatitis C - Vosevi safe, effective in ‘triple-infected’ patients with HCV, HBV, HIV
That's an article Hepatitis C - Vosevi safe, effective in ‘triple-infected’ patients with HCV, HBV, HIV This time, hopefully can give benefits to all of you. well, see you in posting other articles.
You are now reading the article Hepatitis C - Vosevi safe, effective in ‘triple-infected’ patients with HCV, HBV, HIV with the link address https://theleknews.blogspot.com/2018/10/hepatitis-c-vosevi-safe-effective-in.html
0 Response to "Hepatitis C - Vosevi safe, effective in ‘triple-infected’ patients with HCV, HBV, HIV"
Post a Comment